Hiroshi Ogawara

7.3k total citations · 2 hit papers
123 papers, 6.3k citations indexed

About

Hiroshi Ogawara is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Hiroshi Ogawara has authored 123 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 48 papers in Pharmacology and 22 papers in Organic Chemistry. Recurrent topics in Hiroshi Ogawara's work include Microbial Natural Products and Biosynthesis (43 papers), Antibiotic Resistance in Bacteria (19 papers) and Carbohydrate Chemistry and Synthesis (16 papers). Hiroshi Ogawara is often cited by papers focused on Microbial Natural Products and Biosynthesis (43 papers), Antibiotic Resistance in Bacteria (19 papers) and Carbohydrate Chemistry and Synthesis (16 papers). Hiroshi Ogawara collaborates with scholars based in Japan, United States and India. Hiroshi Ogawara's co-authors include Tetsu Akiyama, Shun‐ichi Watanabe, Yuko Fukami, Shizue Nakagawa, Masabumi Shibuya, Junko Ishida, Kumao Toyoshima, Tadashi Yamamoto, Michiko Nakano and Hikoichi Sakai and has published in prestigious journals such as Science, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Hiroshi Ogawara

119 papers receiving 6.0k citations

Hit Papers

Genistein, a specific inh... 1986 2026 1999 2012 1987 1986 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Ogawara Japan 24 3.1k 1.4k 1.3k 982 609 123 6.3k
Airo Tsubura Japan 41 2.5k 0.8× 609 0.4× 1.2k 0.9× 673 0.7× 220 0.4× 315 5.8k
Yuko Fukami Japan 16 2.2k 0.7× 1.2k 0.8× 574 0.5× 724 0.7× 138 0.2× 41 4.3k
Richard A. Franklin United States 41 5.8k 1.8× 853 0.6× 2.4k 1.9× 406 0.4× 404 0.7× 146 9.5k
James M. Phang United States 53 4.9k 1.6× 656 0.5× 1.8k 1.4× 828 0.8× 310 0.5× 138 8.4k
Gail E. Sonenshein United States 62 6.7k 2.1× 925 0.7× 2.8k 2.2× 1.0k 1.1× 361 0.6× 155 10.9k
George P. Studzinski United States 43 3.5k 1.1× 1.3k 0.9× 1.2k 1.0× 790 0.8× 134 0.2× 180 5.4k
Leonard H. Augenlicht United States 54 6.4k 2.0× 1.6k 1.2× 3.3k 2.7× 1.5k 1.5× 299 0.5× 171 10.6k
Shizue Nakagawa Japan 12 1.8k 0.6× 1.2k 0.8× 513 0.4× 694 0.7× 128 0.2× 17 3.7k
John M. Mariadason Australia 49 5.3k 1.7× 1.1k 0.8× 2.8k 2.2× 834 0.8× 235 0.4× 139 8.3k
Masayoshi Imagawa Japan 38 6.3k 2.0× 323 0.2× 1.1k 0.9× 1.5k 1.5× 218 0.4× 157 9.3k

Countries citing papers authored by Hiroshi Ogawara

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Ogawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Ogawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Ogawara more than expected).

Fields of papers citing papers by Hiroshi Ogawara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Ogawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Ogawara. The network helps show where Hiroshi Ogawara may publish in the future.

Co-authorship network of co-authors of Hiroshi Ogawara

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Ogawara. A scholar is included among the top collaborators of Hiroshi Ogawara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Ogawara. Hiroshi Ogawara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogawara, Hiroshi. (2020). Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs. The Journal of Antibiotics. 74(1). 24–41. 44 indexed citations
2.
Ogawara, Hiroshi, et al.. (2008). Expression and Characterization of theStreptomyces coelicolorSerine/Threonine Protein Kinase PkaD. Bioscience Biotechnology and Biochemistry. 72(3). 778–785. 9 indexed citations
3.
Ueki, Masaaki, Shigeru Watanabe, Takeshi Saito, et al.. (2001). Synthesis and chain length–anti-HIV activity relationship of fully N- and O-sulfated homooligomers of tyrosine. Bioorganic & Medicinal Chemistry. 9(2). 487–492. 8 indexed citations
4.
Higashi, Kyoichiro, et al.. (1995). Cochlioquinone A, an Inhibitor of Diacylglycerol Kinase.. The Journal of Antibiotics. 48(10). 1076–1080. 18 indexed citations
5.
Ogawara, Hiroshi, et al.. (1992). Effects of Isoflavone Compounds on the Activation of Phospholipase C.. Chemical and Pharmaceutical Bulletin. 40(1). 157–160. 17 indexed citations
7.
Higashi, Kyoichiro & Hiroshi Ogawara. (1991). INHIBITION OF INOSITOL PHOSPHOLIPID SIGNALING BY ISOFLAVONE COMPOUNDS. Journal of Pharmacobio-Dynamics. 14(12). 2 indexed citations
8.
Akiyama, Tetsu & Hiroshi Ogawara. (1991). [30] Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods in enzymology on CD-ROM/Methods in enzymology. 201. 362–370. 375 indexed citations
9.
Ogawara, Hiroshi, et al.. (1991). Change of ras-Transformed NRK-Cells Back to Normal Morphology by Mycalamides A and B, Antitumor Agents from a Marine Sponge.. Chemical and Pharmaceutical Bulletin. 39(8). 2152–2154. 33 indexed citations
10.
Ogawara, Hiroshi. (1989). Genes Cloned from Streptomyces Species and Related Genes. Actinomycetologica. 3(1). 9–34. 2 indexed citations
11.
Akiyama, Tetsu, Terumi Saito, Hiroshi Ogawara, K Toyoshima, & Takashi Yamamoto. (1988). Tumor promoter and epidermal growth factor stimulate phosphorylation of the c-erbB-2 gene product in MKN-7 human adenocarcinoma cells.. Molecular and Cellular Biology. 8(3). 1019–1026. 68 indexed citations
12.
Ogawara, Hiroshi, et al.. (1987). A SPECIFIC INHIBITOR FOR TYROSINE PROTEIN KINASE. Journal of Pharmacobio-Dynamics. 10(2). 1 indexed citations
13.
14.
Ogawara, Hiroshi, et al.. (1985). A new 5'-nucleotidase inhibitor, nucleoticidin. II. Physico-chemical properties and structure elucidation.. The Journal of Antibiotics. 38(2). 157–160. 3 indexed citations
15.
Akiyama, Tetsu, et al.. (1983). Alteration of adenylate cyclase activity by phosphorylation and dephosphorylation. Biochemical and Biophysical Research Communications. 112(1). 250–256. 4 indexed citations
16.
Nakano, Michiko, Kenji Ozawa, & Hiroshi Ogawara. (1980). Isolation and characterization of a plasmid pSL1 fromStreptomyces lavendulae. FEMS Microbiology Letters. 9(2). 111–113. 14 indexed citations
17.
Nakano, Michiko, Kenji Ozawa, & Hiroshi Ogawara. (1980). Possible involvement of a plasmid in arginine auxotrophic mutation of Streptomyces kasugaensis. Journal of Bacteriology. 143(3). 1501–1503. 6 indexed citations
18.
Ogawara, Hiroshi, et al.. (1980). Penicillin-binding proteins in Bacillus subtilis. The effects on penicillin-binding proteins and the antibacterial activities of .BETA.-lactams.. The Journal of Antibiotics. 33(6). 614–619. 9 indexed citations
19.
Ogawara, Hiroshi. (1976). A specific cephalosporin-binding protein ofCitrobacter freundii. Biochimica et Biophysica Acta (BBA) - Protein Structure. 420(1). 155–164. 9 indexed citations
20.
Ogawara, Hiroshi & H. J. Cahnmann. (1972). Nonenzymic synthesis of iodothyronine residues in thyroglobulin. Biochimica et Biophysica Acta (BBA) - Protein Structure. 257(2). 328–338. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026